my private podcast channel
The billionaire founder showed several female employees at SpaceX an unusual amount of attention or pursued them. WSJ's Joseph Palazzolo describes the revelations.
Further Reading:
-Elon Musk’s Boundary-Blurring Relationships With Women at SpaceX
Further Listening:
-Money, Drugs, Elon Musk and Tesla's Board
Learn more about your ad choices. Visit megaphone.fm/adchoices
The nation’s first congestion-pricing plan was set to take effect at the end of June. But last week, New York Gov. Kathy Hochul called to indefinitely delay the program. WSJ's Jimmy Vielkind unpacks the surprising move and explores why Hochul made the 11th hour change.
Further Reading:
-New York Gov. Kathy Hochul Abruptly Halts Manhattan Congestion Pricing
Further Listening:
-NYC’s Food Delivery Workers Fight for a Minimum Wage
-New York City's 'De Facto Ban' on Airbnb
Learn more about your ad choices. Visit megaphone.fm/adchoices
The fast-fashion giant hoped to have a splashy U.S. public offering this year. WSJ's Shen Lu explains how the divide between Beijing and Washington got in the way.
Further Reading:
- Shein Promised to Have a Big U.S. IPO. Its China Roots Got in the Way.
- Fast-Fashion Giant Shein Files to Go Public
Further Listening:
- Shein Took Over Fast Fashion. Then Came the Backlash.
- The Mysterious CEO Leading Shein to an IPO
Learn more about your ad choices. Visit megaphone.fm/adchoices
The rising popularity of GLP-1 drugs could cause all kinds of ripple effects.
According to one estimate, 9% of the U.S. population could be on Ozempic or similar medications by 2030. Meanwhile, drugmakers are already developing the next generation of weight-loss drugs and researchers are studying the possible health benefits beyond weight loss and diabetes, including addiction.
In the final episode of our series we ask: What could all this development mean for businesses, from the food sector to airlines? And who wins and who loses in the post-Ozempic economy?
Guests include: David Ricks, CEO of Eli Lilly; and Mehdi Farokhnia, an addiction researcher at the National Institutes of Health.
Listen to Episodes 1, 2 and 3 of “Trillion Dollar Shot” here.
Learn more about your ad choices. Visit megaphone.fm/adchoices
There is a new contender in the cola wars, and it isn’t a cola. It’s Dr Pepper. WSJ’s Jennifer Maloney unpacks how after decades as a distant competitor, Dr Pepper has climbed the soda ranks with help from hefty marketing, novel flavors and TikTok videos.
Further Reading:
- Dr Pepper Ties Pepsi as America’s No. 2 Soda
Further Listening:
- The Agony and Ecstasy of Tab
Learn more about your ad choices. Visit megaphone.fm/adchoices
President Biden unveiled a last-ditch effort to lower illegal crossings at the southern border this week. The move focuses on asylum seekers, and the policy is similar to one that former President Trump tried in 2018. WSJ’s Michelle Hackman describes the policy and tries to answer the question: why now?
Further Reading:
-Biden Issues Executive Actions on Immigration: What to Know
Further Listening:
-What the End of Title 42 Means for U.S. Immigration Policy
-What Trump's Immigration Restrictions Could Mean for the Economy
Learn more about your ad choices. Visit megaphone.fm/adchoices
For much of his career, Biden built a reputation as a master negotiator. He’s known for his detailed knowledge of issues—and for hitting his stride when the pressure was on. Now, 81-year-old Biden is the oldest person to hold the presidency. WSJ's Annie Linskey and Siobhan Hughes go behind closed doors where some who have worked with him describe a president who appears slower.
Further Reading:
- Behind Closed Doors, Biden Shows Signs of Slipping
Further Listening:
- Inside the White House's Scramble to Avert a Bigger Middle East War
Learn more about your ad choices. Visit megaphone.fm/adchoices
Astro Teller, the CEO of Aphabet’s X, runs a lab dedicated to solving some of the world’s most pressing problems while also coming up with viable businesses. After he spoke at the WSJ’s Future of Everything festival, we sat down with him to talk about A.I., self-driving cars, and the changing economy of tech.
Further Watching:
-Astro Teller’s Meaning of Life
Further Listening:
-Google CEO Sundar Pichai on How AI Could Change Search
-The Future of Self-Driving Cars Is Here
Learn more about your ad choices. Visit megaphone.fm/adchoices
Claudia Sheinbaum, the former mayor of Mexico City, will become Mexico’s first female president. Sheinbaum has pledged to be a continuation of her predecessor, Andrés Manuel López Obrador. WSJ’s José de Córdoba explains the two politicians’ close ties, and what her administration could mean for Mexico-U.S. relations.
Further Reading:
- Claudia Sheinbaum Elected as Mexico’s First Female President
- The Most Dangerous Job in Mexican Politics: Running for Mayor
Further Listening:
- Texas Took On Border Security. Is It Working?
- When the Drug Cartel Takes Over
Learn more about your ad choices. Visit megaphone.fm/adchoices
Bradley Olson has tried a lot of different diets over his 20-year weight-loss journey, including popular programs like WeightWatchers. But nothing was as successful for him as Mounjaro, one in a new class of drugs that people are taking for weight loss.
In this episode, Brad talks about his experience on the medicine and grapples with everything the drug couldn’t fix, from his self image to our food system. He confronts the ghosts of diets past and wades into the larger cultural conversation around weight loss. Guests include: Gary Foster from WeightWatchers; Virgie Tovar, a body positivity advocate; Dr. Robert Lustig, an endocrinologist.
Listen to Episodes 1 and 2 of “Trillion Dollar Shot” now.
Learn more about your ad choices. Visit megaphone.fm/adchoices